ACRV vs. SSO
ACRV (Acrivon Therapeutics Inc. Common Stock) is a stock, while SSO (ProShares Ultra S&P500) is Leveraged Equities fund tracking the S&P 500. Over the past 3 years, ACRV returned -50.76%/yr vs 33.83%/yr for SSO. At a 0.26 correlation, their price movements are largely independent.
Performance
ACRV vs. SSO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACRV achieves a -32.37% return, which is significantly lower than SSO's 12.95% return.
ACRV
- 1D
- 3.16%
- 1M
- -6.86%
- YTD
- -32.37%
- 6M
- -29.74%
- 1Y
- 38.14%
- 3Y*
- -50.76%
- 5Y*
- —
- 10Y*
- —
SSO
- 1D
- -2.86%
- 1M
- -3.30%
- YTD
- 12.95%
- 6M
- 10.86%
- 1Y
- 42.28%
- 3Y*
- 33.83%
- 5Y*
- 17.91%
- 10Y*
- 24.26%
ACRV vs. SSO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ACRV Acrivon Therapeutics Inc. Common Stock | -32.37% | -59.97% | 22.36% | -57.29% | -13.71% |
SSO ProShares Ultra S&P500 | 12.95% | 26.19% | 43.48% | 46.65% | -6.68% |
Correlation
The correlation between ACRV and SSO is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Nov 15, 2022 | 0.26 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACRV vs. SSO — Risk / Return Rank
ACRV
SSO
ACRV vs. SSO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Acrivon Therapeutics Inc. Common Stock (ACRV) and ProShares Ultra S&P500 (SSO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACRV | SSO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.29 | ||
| Sortino ratioReturn per unit of downside risk | -0.96 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.30 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.67 | 2.34 | -1.67 |
| Martin ratioReturn relative to average drawdown | 1.26 | 9.90 | -8.64 |
Loading charts...
Drawdowns
ACRV vs. SSO - Drawdown Comparison
The maximum ACRV drawdown since its inception was -95.47%, which is greater than SSO's maximum drawdown of -84.67%. Use the drawdown chart below to compare losses from any high point for ACRV and SSO.
Loading charts...
Drawdown Indicators
| ACRV | SSO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.47% | -84.67% | -10.80% |
Max Drawdown (1Y)Largest decline over 1 year | -57.14% | -18.17% | -38.97% |
Max Drawdown (3Y)Largest decline over 3 years | -92.31% | -35.21% | -57.10% |
Max Drawdown (5Y)Largest decline over 5 years | — | -46.73% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -59.34% | — |
Current DrawdownCurrent decline from peak | -92.97% | -6.70% | -86.27% |
Average DrawdownAverage peak-to-trough decline | -70.67% | -19.53% | -51.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.37% | 4.28% | +26.09% |
Volatility
ACRV vs. SSO - Volatility Comparison
Acrivon Therapeutics Inc. Common Stock (ACRV) has a higher volatility of 14.33% compared to ProShares Ultra S&P500 (SSO) at 9.70%. This indicates that ACRV's price experiences larger fluctuations and is considered to be riskier than SSO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACRV | SSO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.33% | 9.70% | +4.63% |
Volatility (6M)Calculated over the trailing 6-month period | 72.91% | 19.65% | +53.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.04% | 24.92% | +67.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 104.09% | 33.85% | +70.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 104.09% | 35.93% | +68.16% |
Dividends
ACRV vs. SSO - Dividend Comparison
ACRV has not paid dividends to shareholders, while SSO's dividend yield for the trailing twelve months is around 0.65%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACRV Acrivon Therapeutics Inc. Common Stock | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SSO ProShares Ultra S&P500 | 0.65% | 0.68% | 0.85% | 0.18% | 0.50% | 0.18% | 0.20% | 0.50% | 0.75% | 0.39% | 0.51% | 0.63% |
Frequently Asked Questions
ACRV and SSO have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACRV has higher volatility (14.33%) compared to SSO (9.70%). In terms of maximum drawdown, ACRV dropped -95.47% vs SSO's -84.67%.
SSO currently has the higher Sharpe Ratio (1.71 vs 0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACRV and SSO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer